Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 4c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.35), $0.04 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance